Society ❯ Reproductive Rights

Abortion Access

Legal Challenges Medication Abortion Medication Abortions Legislation Public Opinion Public Health Legislative Actions Public Policy State Legislation Political Advocacy Telehealth Legal Restrictions Travel Funding Medication Abortion Availability Geographic Disparities Public Health Crisis Supreme Court Arizona Abortion Access Act Healthcare Access Healthcare Policy State Regulations Legal History Legal Protections Abortion Pills Medical Abortions Crisis Pregnancy Centers Chemical Abortions Political Reactions Coerced Abortions State Policies Medication Abortion Statistics Pro-Life Movement Health Risks State Responses Health Equity Legal Disputes Contraceptive Choices Federal Legislation Abortion Laws Personal Choices Minor Rights Pro-life Movement Online Censorship

Live Action Urges HHS and FDA to Suspend Mifepristone After Undercover Planned Parenthood Calls

The release intensifies pressure during the FDA’s data-gathering phase of a promised safety review.

Republicans Press Trump Administration to Halt Mail-Order Abortion Pills Crossing State Lines

Texas and Florida Sue FDA to Overturn Mifepristone Approvals and Mail-Order Access

Florida Sues Planned Parenthood Over ‘Safer Than Tylenol’ Abortion Pill Claim, Seeks $350 Million

Senate Democrats Press FDA on Mifepristone Review After Court Strikes Down Restrictions

GOP Senators Press FDA Over Generic Abortion Pill Approval

FDA Opens Mifepristone Safety Review as Republicans Move to Curb Mail and Telehealth Access

Appeals Court Lets Trump Administration Enforce Medicaid Cutoff Hitting Planned Parenthood

Texas Legislature Passes HB7 Targeting Abortion Pill Distribution With Private Lawsuits

Texas AG Moves to Compel New York Clerk to Enforce Abortion Pill Ruling

Texas Man’s Wrongful-Death Suit Invokes Comstock Act to Challenge Telehealth Abortion Shield Laws

Fourth Circuit Affirms West Virginia’s Restriction on Abortion Pill Mifepristone

FDA Commissioner Pledges Safety Review of Abortion Pill Mifepristone

HHS Orders FDA Review of Mifepristone Amid Debate Over Flawed Safety Study